|Table of Contents|

Inhibitory Effect of Erianin on Hepatocellular Carcinoma (HCC) Huh7 Cells(PDF)

Chinese Journal of Applied & Environmental Biology[ISSN:1006-687X/CN:51-1482/Q]

Issue:
2011 05
Page:
662-665
Research Field:
Articles
Publishing date:

Info

Title:
Inhibitory Effect of Erianin on Hepatocellular Carcinoma (HCC) Huh7 Cells
Author(s):
SU PengWANG JingAN JunxiaZHU QiyuLU XiaoxiaTANG Yaxiong
(Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China)
Keywords:
erianin hepatocellular carcinoma (HCC) Huh7 proliferation apoptosis cell cycle
CLC:
R965 : Q949.718.430.6
PACS:
DOI:
10.3724/SP.J.1145.2011.00662
DocumentCode:

Abstract:
Erianin, a low molecular-weight natural product isolated from Dendrobium chrysotoxum Lind., is often used as an anti-pyretic and an analgesic in traditional Chinese medicine. Herein, this study evaluated the erianin’s effect on cell proliferation, apoptosis and cell cycle progression of hepatocellular carcinoma (HCC) Huh7 cancer cells especially. The results in vitro demonstrated that erianin significantly suppressed proliferation of Huh7 cancer cells in a dose- and time-dependent manner which was associated with induced apoptosis and cell cycle G2-M arrest, and the IC50 value was 37.4 nmol/L after 48 h exposure to erianin. Mechanistically, erianin could inhibit Akt activation, down-regulate the expression of Mcl-1 protein, and activate the cleavage of PARP in a dose- and time-dependent manner, leading to marked inhibitory effect of Huh7 cells. These findings suggest that erianin may be a promising antitumor drug for prevention and treatment of HCC. Fig 5, Ref 17

References

1 Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis. World J Gastroenterol, 2008, 14 (27): 4300~4308
2 Tsao AS, Kim ES, Hong WK. Chemoprevention of cancer. CA Cancer J Clin, 2004, 54 (3): 150~180
3 Ding XY (丁小余), Zhang WM (张卫明), Wang ZT (王峥涛), Xu LS (徐珞珊). Summarization of the studies of taxonomy and pharmacognosy of ethnological materials of Dendrobium. Chin Acad Med Mag Org (中国医学生物技术应用), 2003, 8(1): 1~14
4 Chen XM (陈晓梅), Guo SX (郭顺星). Advances in the research of constituents and pharmacology of Dendrobium. Nat Prod Res & Dev (天然产物研究与开发), 2001, 13 (1): 70~75
5 Li YM, Wang H, Liu GQ. Erianin induces apoptosis in human leukemia HL-60 cells. Acta Pharmacol Sin, 2001, 22 (11): 1018~1022
6 Gong YQ, Fan Y, Wu DZ, Yang H, Hu ZB, Wang ZT. In vivo and in vitro evaluation of erianin, a novel anti-angiogenic agent. Eur J Cancer, 2004, 1 (41): 1554~1565
7 Gong YQ, Fan Y, Liu L, Wu DZ, Chang ZL, Wang ZT. Erianin induces a JNK/SAPK-dependent metabolic inhibition in human umbilical vein endothelial cells. In vivo, 2004, 18 (2): 223~228
8 Hong W (洪卫), Ma SL (马胜林), Du LB (杜灵彬), Feng JG (冯建国), Ling YT (凌雨田), Mou HZ (牟瀚周), Guo Y (郭勇). Experimental study of erianin inducing in gastric carcinoma. China Cancer (中国肿瘤), 2008, 17 (6): 499~501
9 Tang Y, Simoneau AR, Xie J, Shahandeh B, Zi X. Effects of the kava chalcone flavokawain A differ in bladder cancer cells with wild-type versus mutant p53. Cancer Prev Res, 2008, 1 (6): 439~451
10 Tang Y, Simoneau AR, Liao WX, Yi G, Hope C, Liu F, Li S, Xie J, Holcombe RF, Jurnak FA, Mercola D, Hoang BH, Zi X. WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells. Mol Cancer Ther, 2009, 8 (2): 458~468
11 Tang Y, Li X, Liu Z, Simoneau AR, Xie J, Zi X. Flavokawain B, a kava chalcone, exhibits robust apoptotic mechanisms on androgen receptor-negative, hormone-refractory prostate cancer cell lines and reduces tumor growth in a preclinical model. Intern J Cancer, 2010, 127 (8): 1758~1768
12 Yee DS, Tang Y, Li X, Liu Z, Guo Y, Ghaffar S, McQueen P, Atreya D, Xie J, Simoneau AR, Hoang BH, Zi X. The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition. Mol Cancer, 2010, 9 (1): 162
13 Tang Y, Parmakhtiar B, Simoneau AR, Xie J, Fruehauf J, Lilly M, Zi X. Lycopene enhances docetaxel’s effect in castration-resistant prostate cancer associated with insulin-like growth factor I receptor levels. Neoplasia, 2011, 13 (2): 108~119
14 Gao YR (高雅蓉), An JX (安君霞), Zhu QY (朱启彧), Li F (李甫), Ma CY (马超英), Wang MK (王明奎), Tang YX (唐亚雄). Inhibitory effect of Raddeanin A in human non-small cell lung cancer H460 cells. Chin J Appl Environ Biol (应用与环境生物学报), 2010, 12 (5): 637~641
15 Oliver FJ, de la Rubia G, Rolli V, Ruiz-Ruiz MC, de Murcia G, Murcia JM. Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. J Biol Chem, 1998, 273 (50): 33533~33539
16 Chen KF, Yeh PY, Yeh KH, Lu YS, Huang SY, Cheng AL. Down-regulation of phospho-Akt is a major molecular determinant of Bortezomib-induced apoptosis in hepatocellular carcinoma cells. Cancer Res, 2008, 68: 6698~6707
17 Wolfgang S, Doris L, Sabine S, Daniel C, Katharina S, Susanne RR, Martin B, Richard C, Brett PM, Markus PR, Volker W. Mcl-1 overexpression in Hepatocellular Carcinoma: A potential target for antisense therapy. J Hepatol, 2006, 44 (1): 151~157

Memo

Memo:
-
Last Update: 2011-10-25